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httpSuccessful stent graft repair of multiple
thoracoabdominal mycotic aortic aneurysms
in the presence of Kommerell diverticulum
and complicated by aortoesophageal ﬁstula
Debra S. T. Chong, MBBS, MRCS,a,b Hamish Hamilton, FRCS,a Jason Constantinou, MD, FRCS,a
Meryl Davis, FRCS,a Muntzer Mughal, FRCS,b,c and Krasnodar Ivancev, MD, PhD,a London,
United Kingdom
We describe the management of a woman who presented with synchronous mycotic aortic aneurysms of the aortic arch in
the presence of Kommerell diverticulum, the distal thoracic, and the juxtarenal aorta. A staged stent graft repair was
undertaken due to rapid expansion of the aneurysms, which involved placement of multiple thoracic quadruple-fenestrated
and infrarenal bifurcated stent grafts. Despite complications of an aortoesophageal ﬁstula and transitory spinal cord
ischemia, she has been managed successfully and is doing well at 36 months. This case illustrates that stent graft repair of
mycotic aneurysms can offer a successful treatment option in selected patients. (J Vasc Surg Cases 2015;1:197-200.)Mycotic aortic aneurysms (MAAs) present many
challenges to treatment. Open surgical repair of these
aneurysms, considered to be the radical treatment for
removing the infected segment of the aorta, is associated
with poor outcomes. Endovascular repair offers a more
promisingmodality. We describe our successful management
of such a complex case. Formal consent for the publication of
this case report was obtained from the patient.CASE REPORT
A 54-year-old Caucasian woman presented with right-sided
sciatic nerve pain, generalized weakness, lethargy, and weight
loss. There was no history of fever or recent travel abroad. A
urinary tract infection positive for Escherichia coli was diagnosed
and appropriate antibiotic therapy initiated.
Seven years earlier she presented with acute renal failure and hy-
pertension with bilateral hydronephrosis. Computed tomography
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treated with tamoxifen and prednisolone for 6 months, with a return
to normal renal function. She failed to attend follow-up. Of note, her
father had died of a ruptured abdominal aortic aneurysm at age
59 years.
CT angiography (CTA) revealed multilevel thoracic and
abdominal aneurysms. This included an aneurysm at the origin
of an aberrant right subclavian artery constituting a Kommerell
diverticulum measuring 6.5 cm, with a 4.7-cm-diameter aneurysm
in the distal thoracic aorta, and a juxtarenal 3.8-cm-diameter
abdominal aortic aneurysm, with multiple enlarged lymph nodes
suggestive of an infective or inﬂammatory process.
Positron emission tomography using 18F-ﬂuorodeoxyglucose
revealed an uptake suggestive of aortitis or mycotic aneurysms and
discitis at the level of L3 and L4. Rheumatology and infectious
diseases advice was gained, and due to the dual pathology, she
was commenced on antibiotic therapy with intravenous piperacillin
and tazobactam and high-dose steroids (prednisolone >30 mg).
These antibiotics were replaced 7 days with ceftriaxone to facilitate
long-term regimen.
Blood investigations at the initial presentation revealed a
white cell count of 35  109/L (high) with a neutrophilia and a
C-reactive protein of 384 mg/dL (high). Rheumatoid factor was
raised at 23 IU/mL, C3 was 225 IU/mL, and C4 was 28 IU/mL.
Results of the remaining autoimmune and viral screen were negative.
Despite multiple blood cultures, these remained negative.
She developed pain 1 week later, and a repeat CTA revealed ex-
pansions in the size of the saccular aneurysm of the Kommerell diver-
ticulum from 6.5 to 7.7 cm, of the fusiform thoracic aneurysm from
4.7 to 6.6 cm, and of the juxtarenal component from 3.8 to 4.4 cm
(Fig 1). The treatment options were discussed with the patient, and
after anesthesia input, an endovascular option was deemed to be
lower risk than an open thoracoabdominal repair, taking into account
her borderline preoperative cardiac and respiratory status.
She underwent bilateral carotid-subclavian bypasses using
Dacron (DuPont, Wilmington, Del) 6-mm grafts to preserve197
Fig 1. Cross-sectional images: (A) Initial computed tomography angiography (CTA) demonstrates the thoracic
component of the mycotic aortic aneurysms (MAAs). B, The CTA 1 week later showed rapid expansion.
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TX2 thoracic stent grafts (Cook Medical, Bloomington, Ind),
followed by bilateral subclavian artery embolizations bilaterally
with Amplatzer plugs (St. Jude Medical, St. Paul, Minn).
A CTA 1 week later revealed further enlargement (from
4.4 to 5.4 cm) of the juxtarenal aneurysm, necessitating surgery
with a quadruple-fenestrated device and an infrarenal bifurcated
stent graft (Cook Medical). The fenestrated device was used
off-the-shelf, having been customized for another patient (Fig 2)
and modiﬁed on the table.
Shemade a good recovery and was discharged home 27 days af-
ter her initial presentation. Six days later she was readmitted with
lower limb weakness, urinary and fecal incontinence, and spinal
cord ischemia secondary to hypotension as a consequence of diar-
rhea and dehydration. Intravenous ﬂuids, inotropic support, and ce-
rebrospinal ﬂuid drainage resulted in a speedy recovery #24 hours.
Onemonth later shepresentedwith a1-weekhistoryof sweating,
malaise, and chest, shoulder, and back pain. CTA demonstrated gas
within the thoracic aortic sac, and a Gastrograﬁn (BraccoDiagnostics
Inc, Princeton, NJ) swallow and esophagogastroduodenoscopy
revealed an aortoesophageal ﬁstula 30 cm from the incisors. Steroids
were withdrawn. An emergency cervical esophagostomy, feedingjejunostomy, and venting gastrostomy was performed. Mediastinitis,
with no pleural contamination, was noted at surgery.
Esophageal reconstruction was conducted successfully
2 months later using a stomach conduit based on the greater
curvature and tunnelled retrosternally. A hand-sewn cervical esoph-
agogastric anastomosis restored the alimentary tract. A subsequent
CTA demonstrated satisfactory stent graft positioning, with patent
visceral arteries and complete collapse of the aneurysms, which
were considered to have drained via the aortoesophageal ﬁstula.
She presented again 7months with sepsis requiring intravenous
antibiotics. CTA identiﬁed a new ﬂuid collection around the distal
thoracic stent grafts, not deemed to require drainage. Dysphagia
and loss of weight were also noted due to an anastomotic stricture,
which was successfully dilated at esophagogastroduodenoscopy.
A follow-up CTA at 30 months showed unchanged good
results. Forty months after presentation, she remains well and
has returned to normal activities of daily living. She remains on
life-long antibiotics and regular surveillance.
DISCUSSION
This case highlights the complex nature of treating
patients with MAAs, especially in patients in whom open
Fig 2. Computed tomography angiograms (CTAs) before stenting show multiple mycotic aortic aneurysms (MAAs) in
(A) three-dimensional and in (B) maximum intensity pixel reconstructions. C, A three-dimensional CTA at 30 months
shows patency of all the visceral vessels after quadruple-fenestrated stent graft repair.D, A CTA cross-sectional image at
30 months at the same level as Fig 1 shows a complete reduction in the size of the aneurysm.
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vascular procedures were undertaken.
It is important to highlight the dichotomy of the
diagnosis in this case and differentiating between an in-
ﬂammatory and infective etiology. No positive blood cul-
tures were identiﬁed in this patient, hence the dual
therapy.
Semba et al1 published a series of three patients in
whom an endovascular approach was undertaken for
infected thoracic aneurysms. This modality in the presence
of infection remains controversial. Other groups have also
shown that endovascular stenting in the presence of a
mycotic aneurysm does not equate to poor outcomes,
despite not removing the infected aneurysms.2-4
In the treatment of MAAs, a period of targeted
antibiotic therapy is advocated to allow sepsis suppression(with negative blood cultures and normal inﬂammatory
markers) and optimization preoperatively resulting in
better outcomes.3 However, patients with MAAs often
present as an emergency, which may preclude a period of
antibiotic therapy before surgery. Concurrent therapy
with other agents, such as steroids, as in this patient, can
also contribute to adverse effects, including poor healing
and development of an aortoesophageal ﬁstula.
A systematic review looked at the predictive factors
and outcomes for MAAs treated with endovascular stent
grafting5 and concluded that factors such as age
$65 years, rupture on presentation, association with
aortoenteric or aortobronchial ﬁstulae, and fever at the
time of operation were positive predictive factors for persis-
tent infection. The 12-month survival rate for patients with
no evidence of persistent infection at the time of operation
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infection at the time of surgery was 39%.5 The administra-
tion of antibiotics for >1 week and adjunctive procedures,
such as surgical débridement or percutaneous drainage,
contributed to a better outcome.
Historically, endoluminal repair of MAAs was consid-
ered a bridging procedure before open surgery. However,
a recent international collaboration to elucidate the
durability of stent grafts in the treatment of MAAs6
reported good short-term outcome (91% survival at
30 days), but fatal infection-related complications were
high in the ﬁrst postoperative year (19%). Cessation of anti-
biotic therapy is strongly correlated with fatal infection-
related complications.
CONCLUSIONS
An endovascular approach is valid in high-risk patients.
However, fastidious monitoring is mandatory because of
the unpredictable nature of MAAs. Careful planning and
surveillance are imperative to achieve good outcomes.
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